EFG International AG Makes New Investment in Envista Holdings Corporation $NVST

EFG International AG bought a new stake in Envista Holdings Corporation (NYSE:NVSTFree Report) during the 2nd quarter, Holdings Channel.com reports. The institutional investor bought 181,986 shares of the company’s stock, valued at approximately $4,797,000.

A number of other hedge funds have also made changes to their positions in the company. Royal Bank of Canada grew its stake in Envista by 26.6% in the 1st quarter. Royal Bank of Canada now owns 23,240 shares of the company’s stock valued at $401,000 after acquiring an additional 4,885 shares during the last quarter. Millennium Management LLC raised its position in Envista by 218.6% during the first quarter. Millennium Management LLC now owns 383,966 shares of the company’s stock worth $6,627,000 after acquiring an additional 263,442 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Envista by 39.3% in the first quarter. Goldman Sachs Group Inc. now owns 629,140 shares of the company’s stock valued at $10,859,000 after purchasing an additional 177,630 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Envista by 15.5% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 568,982 shares of the company’s stock valued at $9,821,000 after purchasing an additional 76,246 shares in the last quarter. Finally, Prudential Financial Inc. grew its position in shares of Envista by 22.1% in the second quarter. Prudential Financial Inc. now owns 18,785 shares of the company’s stock valued at $367,000 after purchasing an additional 3,395 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on NVST shares. Morgan Stanley set a $23.00 price objective on Envista in a research report on Thursday, August 6th. JPMorgan Chase & Co. increased their target price on Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a report on Thursday, May 7th. Wall Street Zen raised Envista from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Barclays cut their price target on Envista from $34.00 to $32.00 and set an “overweight” rating for the company in a report on Thursday, June 11th. Finally, Mizuho set a $29.00 price objective on Envista in a research report on Thursday, August 6th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $29.31.

Check Out Our Latest Stock Report on NVST

Insiders Place Their Bets

In other Envista news, SVP Mischa Reis sold 8,000 shares of the stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $27.50, for a total transaction of $220,000.00. Following the transaction, the senior vice president owned 27,321 shares of the company’s stock, valued at $751,327.50. This represents a 22.65% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.99% of the company’s stock.

Envista Stock Performance

NYSE:NVST opened at $27.52 on Wednesday. The firm has a 50 day simple moving average of $27.00 and a 200-day simple moving average of $26.36. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.43 and a quick ratio of 2.07. The firm has a market cap of $4.42 billion, a PE ratio of 47.44, a P/E/G ratio of 1.30 and a beta of 0.86. Envista Holdings Corporation has a 1-year low of $18.77 and a 1-year high of $30.42.

Envista (NYSE:NVSTGet Free Report) last announced its earnings results on Wednesday, August 5th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. The firm had revenue of $730.50 million for the quarter, compared to analyst estimates of $716.11 million. Envista had a net margin of 3.33% and a return on equity of 7.88%. Envista’s revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the business earned $0.26 earnings per share. Envista has set its FY 2026 guidance at 1.500-1.550 EPS. On average, equities analysts expect that Envista Holdings Corporation will post 1.53 EPS for the current year.

Envista Company Profile

(Free Report)

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

Read More

Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVSTFree Report).

Institutional Ownership by Quarter for Envista (NYSE:NVST)

Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.